Amber C King

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Cross Sectional

Oxidative Stress

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

American journal of hematology

Clinical case reports

Memorial Sloan Kettering Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Memorial Sloan Kettering Cancer Center Aug 03 2015

United States

Clinical Pharmacy Specialist-Leukemia :: Clinical Pharmacy

Publications

Kitsada Wudhikarn, Amber C King, Mark Blaine Geyer, Mikhail Roshal, Yvette Bernal, Boglarka Gyurkocza, Miguel-Ángel Perales, Jae H Park
Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab. Blood advances 6 (5) (2022)
Amber C King, Taylor M Weis, Andriy Derkach, Somedeb Ball, Manu Pandey, Michael J Mauro, Aaron D Goldberg, Maximilian Stahl, Christopher Famulare, Martin S Tallman, Eunice S Wang, Andrew T Kuykendall, Raajit K Rampal
Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms. American journal of hematology (2021)
Amber C King, Eli L Diamond, Jennifer S Orozco, Hannah R Morse, Linda L Ouyang, Heiko Schöder, Raajit K Rampal
Cobimetinib-induced "dropped head syndrome" and subsequent disease management in an Erdheim-Chester patient. Clinical case reports 7 (10) (2019)